Mitch Phelps
Associate Professor
Pharmaceutics and Pharmaceutical Chemistry
612 Riffe Building


  • Anti-cancer drug development
  • Pharmacometrics; pharmacokinetic/pharmacodynamic modeling and simulation
  • Individualization and optimization of anti-cancer therapies
  • Bioanalytical methodologies applied in PK/PD studies

Professional Interests

Mitch Phelps’ group is involved in both pre-clinical and clinical development of numerous small molecule anti-cancer and immuno-modulatory agents under development here at OSU. Their work aims to understand the mechanisms involved in the absorption, distribution, metabolism, and excretion (i.e. pharmacokinetics, PK) of these agents, and how both the PK and pharmacodynamic (PD) effects of these agents are altered by genetic differences (polymorphisms) among individuals (i.e. pharmacogenetics, PG).


  • 2009-2011: Fellow and Scholar, Center for Clinical and Translational Sciences, The Ohio State University
  • 2004-2005: Predoctoral Traineeship, Department of Defense Breast Cancer Research Program
  • 2005: Biophysics Program, Outstanding Graduate Student Award
  • 2004: Predoctoral Fellowship, Pharmaceutical Research and Manufacturers of America (Fellowship declined due to overlap)
  • 2003-2004: Predoctoral Fellowship, American Foundation for Pharmaceutical Education
  • 2003: Travel Award, Council of Graduate Students, The Ohio State University
  • 2001: Hazel Brown Teaching Award, Ohio State University Department of Physics


  • PhD, 2005, The Ohio State University, Biophysics
  • MLHR, 1999, The Ohio State University, Business Management/Labor and Human Resources
  • BA, 1992, Ohio Wesleyan University, Physics

Recent Publications